IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Accreditation

GO BACK

IMCAS Asia class
Program

Adapt the schedule of the livestreamed class/congress to your time zone

Time zone reference: (UTC-04:00) America, New York

Time zone

Time zone:Change time zone

If you are logged in, change your default time zone in your account

FOCUS ON S01

Injectables - Managing inflammatory complications

Partner of the session

CDSI

Cosmetic Dermatology Society India

India

Cosmetic Dermatology Society India

CDSI aims to bring science to the concept of beauty. Formed in 1997, we are a society of skin and hair care medical professionals with an academic outlook which includes Cosmetic Dermatologists as well as Plastic Surgeons as members. We aim to create awareness among the young cosmetic dermatologists and also to educate them towards the high quality of clinical care and innovation in this particular field. Website: www.cosdermindia.com Email address: cosdermindia@gmail.com Should you have any queries please feel free to contact us on cosdermindia@gmail.com or call us on 9819219787 or 9870007315

Partner of the session

SAARC AAD

Association of Aesthetic Dermatology

India

Room: Channel 1
Date: Saturday 17 October 2020 at 01:00 to 02:00
Format: FOCUS SESSION > lectures covering a major topic of the congress

Chairs

Dr Ronald FEINER

Australia

Dr Amit LUTHRA

Dermatologist

India

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
01:00	Dr Amit LUTHRA	Welcome message from the CDSI & SAARC		107041
01:05	Dr Amit LUTHRA	Injectables: non-vascular complications	View	107042
01:20	Dr Peter VELTHUIS	Use of hyaluronidase in non vascular complications	View	107043
01:35	Dr Kuang Cheng CHANG	Nerve injury caused by injection	View	107648
01:50		Q&A		107047

Go to next session

Recommended sessions

Complications

Fillers: HA (hyaluronic acid)

Dr Amit LUTHRA

Dermatologist

India

Other author(s) :

Welcome message from the CDSI & SAARC

Dr Amit LUTHRA

Dermatologist

India

Other author(s) :

Injectables: non-vascular complications

Objectives: To learn about non vascular complications of Injectables.

Introduction: Injectables give us a great option to treat patients with ageing concerns, enhancements and problem solutions. They do come with their set of issues and can have dramatic and drastic complications.

Materials / method: A review of all non vascular complications with fillers and botulinum toxin A has been done with recommendations on how to avoid them.

Results: Complications reported most often are technique related and dependent on the injection procedure. Better asepsis and knowledge of Anatomy can prevent most of these.

Conclusion: Most of the complications reported are technique related and hence better awareness about the complications will help all injectors.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Peter VELTHUIS

Dermatologist

Netherlands

Other author(s) : Leonie Schelke

Use of hyaluronidase in non vascular complications

Objectives: To understand the potential causes of non-vascular hyaluronic acid filler complications and the way to use hyaluronidase in a sefe way to mend these complications

Introduction: Hyaluronidase (HAse) is your best friend when working with hyaluronic acid (HA) fillers. It is an emergency drug for vascular complications and it should be in your office at any time during treatment. For other HA filler related complications, time is not so essential. But the use of HAse remains the cornerstone of therapy.

Materials / method: In Erasmus University Medical Center we deploy out-patients clinical hours for filler complications. The long-banned non-resorbable (permanent) fillers are most frequently sees as group of offending substances. HA fillers seems to be quite safe. We estimated that about 50% of the HA fillers complications that are referred are caused by flaw in technique of the doctor. A smaller percentage forms the HA filler injections in the vicinity of permanent fillers. These lead to inflammatory reactions that are difficult to mend. Seldomly we acute swelling after treatment or a late-onset inflammation.

Results: Most of the patients from the latter groups have already been treated with HAse by their physician with none or without much effect. We treat them with ultrasound guided injections of Hase. Probably this works better than random injections, since most of our patients are cleared from symptoms after 3-5 treatments. HA fillers longer in situ react more poorly.

Conclusion: Hyaluronidase seems to be exceptionally safe, but we recently saw one patient with slimming of the nose following a small dosage of Hase injections.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Kuang Cheng CHANG

Facial Plastic Surgeon

Taiwan

Other author(s) :

Nerve injury caused by injection

Objectives: Dr. KC Chang collect the symptom of facial nerve injury after injection.

Introduction: THe location and depth of frontal branch,zygomatic branch,buccal branch and marginal mandibular brandh will explain based on anatomic study.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Q&A

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Americas
IMCAS Asia
IMCAS World Congress

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS Asia class Program

FOCUS ON S01

Injectables - Managing inflammatory complications

Chairs

Lectures of the session

Recommended sessions

IMCAS Asia class
Program